Pharmaceutical Approval Update.

Link to article at PubMed

Related Articles

Pharmaceutical Approval Update.

P T. 2018 Jul;43(7):394-395

Authors: Choy M

Abstract
Fostamatinib (Tavalisse) for thrombocytopenia in adults with chronic immune thrombocytopenia; coagulation factor Xa (recombinant), inactivated-zhzo (Andexxa) for the reversal of anticoagulation; epoetin alfa-epbx (Retacrit), a biosimilar for the treatment of anemia.

PMID: 30013295 [PubMed]

Leave a Reply

Your email address will not be published.